InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

IRADIMED CORP

IRMD Clue Score75
United States Fiscal year ends December CIK 0001325618 Results filed 30 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
John Glenn
11 Dec 2025
Chief Financial Officer
Sold after exercise
532
$98.09
$52.18K
John Glenn
11 Dec 2025
Chief Financial Officer
Sold after exercise
14,468
$97.26
$1.41M
James B Hawkins
14 Dec 2023
Director
Sold after exercise
4,277
$44.58
$190.69K
James B Hawkins
13 Dec 2023
Director
Sold after exercise
219
$43.61
$9.55K
James B Hawkins
13 Dec 2023
Director
Sold after exercise
5,000
$42.80
$213.99K
James B Hawkins
12 Dec 2023
Director
Sold after exercise
504
$43.40
$21.87K
James B Hawkins
12 Dec 2023
Director
Sold after exercise
468
$43.40
$20.31K
James B Hawkins
4 Dec 2023
Director
Sold after exercise
4,273
$42.70
$182.47K
James B Hawkins
1 Dec 2023
Director
Sold after exercise
5,259
$43.28
$227.59K
James B Hawkins
15 Feb 2022
Director
Sold after exercise
9,441
$50.22
$474.15K
Showing 250 of 487 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 409
Amendments (4/A) skipped 8
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 138
Sales straight out of an exercise 191
Sales at will 151
Transactions with no price 0
Shares from compensation/vesting 2,091,044
Sales filed before the plan box existed 85
History held since 21 Jul 2014